Innovation begins with curiosity, and at Sanofi, that curiosity drives us to chase the miracles of science every day. Across our global research network, thousands of scientists, engineers, and partners are breaking boundaries in science to bring life-changing solutions to patients faster. Guided by one purpose-we chase the miracles of science to improve people’s lives-we are transforming the future of medicine through discovery, technology, and collaboration.
We are an R&D-driven, AI-powered biopharma company committed to improving people’s lives. Our scientists are advancing groundbreaking research in respiratory, neurology, dermatology, oncology, autoimmune diseases, rare diseases, and more. They are applying a deep understanding of the immune system to unlock its potential and change how we understand, treat, and prevent diseases. With the help of AI-powered innovation that connects data, technology, and biology, we accelerate progress toward precision medicines designed to meet each patient’s unique needs and bring hope to millions worldwide.
From dermatological and respiratory conditions like atopic dermatitis and chronic obstructive pulmonary disease (COPD) to autoimmune and neurological diseases such as multiple sclerosis and autoimmune type 1 diabetes, we’re chasing the miracles of science to address the root causes of diseases, not just the symptoms, to create lasting change. These breakthroughs exemplify our commitment to deliver high-quality, affordable, sustainable medicines and vaccines to those who need them most, ensuring innovation translates into real-world impact. We chase the miracles of science for a healthier, more resilient world, harnessing cutting-edge science, technology, and human insight to shape a better future for generations to come.
Every discovery at Sanofi is a step toward a healthier, more hopeful future. Health unlocks the potential to make dreams a reality, and through innovation, we’re helping people around the world do just that.
Whether it’s developing life-changing vaccines that protect people or pioneering next-generation therapies, we’re united to chase the miracles of science so you can chase your dreams.
MAT-GLB-2506378 I October 2025





